Narrator
Search results
James Patrick Allison (born August 7, 1948) is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center in Houston, Texas.
Oct 22, 2018 · Oct 22, 2018 8:00 AM. Meet the Carousing, Harmonica-Playing Texan Who Won a Nobel for his Cancer Breakthrough. Jim Allison is an iconoclastic scientist who toiled in obscurity for...
Dr. James Allison is Regental Professor and Chair of the Department of Immunology, the Olga Keith Wiess Distinguished University Chair for Cancer Research, Director of the Parker Institute for Cancer Research, Executive Director of the Immunotherapy Platform, and Director of the James P. Allison Institute at MD Anderson Cancer Center.
The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation"
Nov 18, 2019 · Jim Allison, Ph.D., is the chair of Immunology and executive director of the Immunotherapy platform at MD Anderson. He developed ipilimumab, a checkpoint inhibitor that has been approved to treat several cancers, and received the 2018 Nobel Prize in Physiology or Medicine for his work.
Jim Allison, Ph.D., is a MD Anderson Cancer Center scientist who discovered how to unleash the immune system to fight cancer. He received the 2018 Nobel Prize in Physiology or Medicine for his groundbreaking research on immune checkpoint inhibitors.
Oct 1, 2018 · James P. Allison studied a known protein that functions as a brake on the immune system. He realized the potential of releasing the brake and thereby unleashing our immune cells to attack tumors. He then developed this concept into a brand new approach for treating patients.
